|
|
|||||||||||||||||||||||||||||
NantKwest Inc. Buyback
OLI recorded this information on 11/12/2015
NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer (NK) cell to treat cancer and viral infectious diseases. NK cells are the body's first line of defense due to their innate ability to seek and destroy abnormal cells, such as cancer or virally infected cells, without prior exposure or activation by other support molecules required to train and activate adaptive immune cells such as T-Cells. Co. holds the exclusive right to commercialize activated NK cells, a commercially viable natural killer cell line, and a range of genetically modified derivatives capable of killing cancer and virally infected cells.
Open the NK Page at The Online Investor (in a new window) »
|
|